KBC Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Other funds holding EBS
KBC Group's EBS Position: Q4 2023 in Review
KBC Group sold out of Emergent Biosolutions (EBS) in Q4 2023, closing a stake of 2,828 shares — an estimated $10K sold.
KBC Group first reported a position in EBS in Q4 2013 and held it in 19 quarters. The position peaked at $831K in Q4 2020. 134 funds tracked by Wall St. Rank hold EBS as of Q4 2023.
- KBC Group reported no remaining Emergent Biosolutions position as of Q4 2023 after selling out during the quarter.
- KBC Group sold 2,828 Emergent Biosolutions shares in Q4 2023, an estimated $10K.
- KBC Group first reported a position in Emergent Biosolutions in Q4 2013 and held it in 19 quarters.
- KBC Group's Emergent Biosolutions position peaked at $831K in Q4 2020.
- 134 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2023.
Based on KBC Group's 13F filing for Q4 2023, filed 13 Feb 2024.